Kinespir (Diclofenac Diethylamine)

Diclofenac diethylamine blocks cyclooxygenase (COX‑1 and COX‑2) enzymes in the skin and underlying tissues. This inhibition lowers prostaglandin production, which in turn diminishes inflammation, swelling, and the sensation of pain at the site of application.

The amount of Kinespir applied is set by the prescribing healthcare professional based on the severity of the condition, the size of the treatment area, and patient tolerance. Patients should follow the prescriber’s instructions and not exceed the recommended frequency.

Safety data for topical diclofenac during pregnancy and lactation are limited. Because systemic absorption can occur, it is generally advised to avoid use unless the benefit clearly outweighs the potential risk, and only under medical supervision.

To order Kinespir, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Both Kinespir (diclofenac) and ibuprofen gel belong to the NSAID class and provide local analgesia. Diclofenac generally has a slightly stronger COX‑2 inhibition, which may offer more pronounced anti‑inflammatory effects, while ibuprofen may be preferred for patients with specific sensitivities. Clinical choice depends on efficacy, tolerability, and physician judgment.

Kinespir should be stored at room temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture and direct sunlight, and keep it out of reach of children.

Apply a thin layer of Kinespir to clean, dry skin over the affected area. Gently rub in until the product is absorbed. Wash hands after application unless the hands are the treatment site. Do not cover the area with occlusive dressings unless directed by a healthcare professional.

Serious risks include severe allergic reactions such as angioedema, rare but life‑threatening skin conditions like Stevens‑Johnson syndrome, and systemic NSAID toxicity that can affect liver or kidney function. Patients should seek immediate medical attention if they notice swelling of the face, lips, tongue, or widespread rash.

Kinespir should not be used by individuals with a known hypersensitivity to diclofenac, other NSAIDs, or any component of the formulation. It is also contraindicated on broken, infected, or irritated skin, and should be avoided in patients with severe cardiovascular, hepatic, or renal disease unless specifically advised by a physician.